Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

Clinical trial NCT04661384 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04661384
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ependymoma Glioblastoma Medulloblastoma Recurrent Metastatic Malignant Neoplasm in the Leptomeninges

Start date: 2021-03-05
Primary completion: 2027-01-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.